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CMR in 5 (10% ) cases, CCR in 7 (14%) cases and CHR in 22(48%) cases. Only 3(6%) patients 
experienced a relapse in less than a year after remission with Imatinib. On the other hand,8(16%) 
patients with conventional therapy experienced recurrence during the same period o f  time.
Conclusion: The tyrosine kinase inhibitors represent the current most efficient therapy for 
CML in chronic phase. The treatment discontinuation is almost invariably followed by a recurrence. 
The introduction o f  targeted therapy has transformed this disease from an incurable malignancy to a 
manageable chronic condition.
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Introduction: Isotretinoin (13-cis-retinoic acid) is a derivative o f vitamin A, being a 
stereoisomer o f  tretinoin. Applied topically it has the following actions:l. Regulates the 
keratinization, reducing the cohesion between the keratinocytes at the level o f  pilo-sebaceous 
infundibulum and stratum corneum, promoting and preventing peeling and the appearance o f 
comedones; 2. Determines decrease by 50% o f  sebaceous gland size; 3. Inhibits the migration o f  
polymorphonuclear neutrophils induced by leukotriene B4, thus having anti-inflammatory action.
Purpose and objectives: The efficacy and safety o f  treatment with gel Istorexin in acne 
vulgaris Il-nd and Ill-rd degree.
Materials and methods: For observations were subjected 30 patients with acne vulgaris Il-nd 
and Ill-rd degree (12 men and 18 women, mean age 20 ± 4 years). Inclusion criteria according to the 
degree o f  acne severity proposed by G.Plewig,M.Kligman,.2004: 20 patients with acne vulgaris, Il-nd 
degree: more than 20 comedones, 10-20 papulopustular units; 10 patients with acne vulgaris, Ill-rd 
gedree: huge number o f  comedones, over 21 to 30 papulopustular units , up to 5 nodules.The algorithm 
of implementation: 1) thorough cleansing o f the skin with prior degresation;2) Istorexin gel, 2 times 
daily, on the affected areas (eight weeks); 3) Cream complementary for excessive dryness o f skin.
The drug is not applied on skin with other solutions or other dermatoses (eczema, irritant 
contact dermatitis, excoriation...). The evidence o f morphological features in the focal lesion is 
made before the begining o f  the treatment and during the therapy over 1 to 2 months.
Results: At the end o f  the observation period (8 weeks) was noticed: reduction in open and closed 
comedones - in the average o f  28 ± 1 to 9± 1, reduction o f bullous - papulopustular eruptions - from 20 
± 1 to 7 ± 1; skin lesions during the conduct o f the therapy becomes smooth and elastic. Endpoint (8 
weeks): clinical recovery - 15 patients (50%), significant improvement - 8 patients (25%), the total 
clinical score (recovery + improvement) - 75%. Safety Results Notes: 5 patients (16%) reported a 
significant subjective sensations o f dry skin tension on the face, the indication o f moisturizing cosmetic 
preparations allowed coupling o f  this state during the 4-5 days without suspension o f  the gel, this way 
Istorexin gel was maximal efficient and not led to cases o f suspension o f the treatment.
Conclusions: The combined topic acne efficacy profile showed a high efficacy (75%) and a 
maximal safety (in combination with other moisturizing cosmetic drugs) in the treatment o f  patients 
with medium and severe forms o f acne vulgaris, Il-nd and Ill-rd degree.
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